Anakinra in Dengue With Hyperinflammation ( AnaDen )

Clinical trial NCT05611710 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05611710
Sponsor: Oxford University Clinical Research Unit, Vietnam
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dengue Dengue With Warning Signs Severe Dengue Anakinra Immuno-modulation Anti-inflammatory Agents Macrophage Activation Syndrome Hyperinflammatory Syndrome Cytokine Storm

Start date: 2023-01-02
Primary completion: 2025-10-20
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.